Article
New Orleans - Vaccination with a mixture of 12 peptides was immunogenic in 100 percent of melanoma patients tested, even with multiple peptides competing for the same cell surface binding sites, according to Craig L. Slingluff, Jr., M.D.
The Intersection of Ethics, Aesthetics, and Patient Expectations in Dermatology
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
The Unprecedented Phase 1 Results of ET-02 for the Treatment of Androgenic Alopecia
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
LEO Pharma and Gilead Will Develop STAT6 Program for AD and Other Inflammatory Diseases
BioLab Tests Innovative Wound Care Product